We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Medical Division May Be Philips' Biggest Profit Unit in 2004

By HospiMedica staff writers
Posted on 28 Oct 2003
Print article
The best quarterly profit reported in nearly three years by Royal Philips Electronics (Amsterdam, The Netherlands) was announced on October 14, 2003, by the Dutch technology giant. The company had a third-quarter net profit of 124 million euros, in strong contrast to its net loss in 2002 of 330 million euros. The difference was in large part due to the earnings of its Korean joint venture in liquid crystal display (LCD) monitors.

Philips is expecting its medical division to stimulate growth, and already this division's third-quarter operating profit of 138 million euros has exceeded the operating profit of 124 million euros reported by the lighting division. The medical division produces a wide range of imaging systems, patient monitoring systems, and defibrillators. Currently, this division is facing a slow-down in healthcare spending in Europe that has reduced hospital budgets.

In spite of this, analysts are optimistic about the medical division's long-term prospects. "From a profit point of view, it could become the biggest contributor in 2004,” said Victor Bareno, an analyst with SNS Securities (Amsterdam, The Netherlands).




Related Links:
Royal Philips
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Surgeon Stool with Armrests & Backrest
MR4502
New
Fixed Volume Dispense Pump
LPL Series

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.